The management of transitional cell carcinoma of the bladder (TCCB) presents a challenge to urological surgeons due to the diversity of patient factors, stage at presentation and propensity for disease recurrence and progression.
Advances in the last decade have seen an evolution in techniques for diagnosis, treatment and ongoing surveillance. A good understanding of our patients, the disease and the available diagnostic and therapeutic options is essential for the management of this condition. We review the current literature focusing on the merits of recent advances in this field. Given the breadth of the subject, we have deliberately selected only the most relevant and recent advances already in clinical use.
Written by:
Martyn-Hemphill C, Mak D, Khan MS, Challacombe BJ, Bishop CV. Are you the author?
Guy's Hospital, London SE1 9RT, United Kingdom.
Reference: Int J Surg. 2013 Sep 5. pii: S1743-9191(13)01044-3.
doi: 10.1016/j.ijsu.2013.08.018
PubMed Abstract
PMID: 24013072
UroToday.com Bladder Cancer Section
